Ttk Healthcare Limited · NSE:TTKHLTCARE
Ttk Healthcare — Investor Presentation (September 2016)
60 slides from Ttk Healthcare's investor presentation, Sep 14, 2016
Slide 1: Greetings from TTK Healthcare Ltd.
Greetings from TTK Healthcare Ltd.
Slide 2: The TTK Group
The TTK Group Today a Rs. 22 Billion Group • 30 product categories and Manufacturing services commenced in • 16 manufacturing 1950 units Started in 1928 as an • Pioneered several • 12000 employees indenting agency categories in India • Exports to every • Pressure cookers, continent • Founded by Mr.
Slide 3: Diversified Group Structure
Diversified Group Structure TTK Prestige Limited • Consumer durables - Listed • Consumer Products, Pharmaceuticals, Medical TTK Healthcare Limited Devices and Foods - Listed TTK Protective Devices • Contraceptives Limited TTK Services Private • Non-Resident services and KPO Limited Cigna TTK Health
Slide 4: Corporate Philosophy of the TTK Group
Corporate Philosophy of the TTK Group • To provide quality Products & Services at affordable prices. • Innovation by pioneering new business categories. • Excelling in everything that it does and not sacrificing its unique Indian identity. • Trust, transparency, knowledge and relationship.
Slide 5: TTK Healthcare Limited
TTK Healthcare Limited Shareholding • Incorporated in 1958. • Part of TTK Group • IPO in 1985. Oversubscribed by 53 times. • Rights Issue – 1992-93. Public and Inst. • Currently operating through 4 34.57% Promoters 65.43% Strategic Business Units (SBUs) viz., Consumer Products, Pharma, Medical Devic
Slide 6: Board of Directors / Management
Board of Directors / Management Promoter Directors • Mr T T Jagannathan – Non-Executive Chairman • Mr T T Raghunathan – Executive Vice Chairman Non-Independent Directors • Mr R K Tulshan • Mr K Shankaran • Mr S Kalyanaraman – Wholetime Secretary Independent Directors • Mr B N Bhagwat • Dr (Mrs) Vand
Slide 7: TTK Healthcare Limited
TTK Healthcare Limited • Turnover of Rs. 515 Cr. as of FY 15-16 • Presence across categories through 4 Divisions Consumer Pharma- Medical Foods Others Products ceuticals Devices Personal, baby Ethical products Specialised Ready-to-fry and home care for human and devices - Heart snack pellets. produc
Slide 8: The Journey so far ……
The Journey so far …… 1958 - Incorporation 1959 - Commencement of manufacturing of Woodwards Celebrated Gripe water (WGW) at Chennai. 1962 - Commencement of manufacturing of Allopathic Drugs at Chennai. 1984 - Commencement of Animal Welfare Business 1985 - Came out with the first IPO. Over subscribe
Slide 9: The Journey so far….
The Journey so far…. 2001 - Conferred with the National Award for the Successful Commercialisation of Indigenous Technology (Heart Valve). - The Company's Businesses were revamped and restructured Establishment of four strategic business units viz., CPD, Pharma, Medical Devices and Foods; Systematic
Slide 10: The Journey so far ….
The Journey so far …. 2007 - Successful launch of Good Home range of innovative home care products. The brand today has reached a turnover of Rs.28 Crores. Exited distribution of Kiwi/ Brylcreem range of products. 2008 - Setting up of the State-of-the-art Manufacturing Facility for Heart Valves at T
Slide 11: The Journey so far ….
The Journey so far …. 2016 - Setting up of the State-of-the-art Manufacturing Facility for Foods at Jaipur and commenced commercial production in January, 2016. Sales Profit Net Free Cash Year (Rs.in Crores) (Rs.in Crores) (Rs.in Crores) 2015-16 515.03 35.53 60.00
Slide 12: Consumer Products Business
HEALTHCARE Consumer Products Business
Slide 13: Consumer Products Division
Consumer Products Division • Presence across personal, baby and home care categories • Market leadership with strong brands in portfolio Good Home Woodward’s Gripe Skore Eva – Deo, Talc & Lip care (Air fresheners & Water (Contraceptives) scrubbers)
Slide 14: Woodwards
Woodwards WOODWARDS • One of the oldest brands – over 160 years. • Only Pan India Brand of Gripe Water. • Trusted Household name. • Non‐alcoholic formulation. • Volume growth of almost 10% CAGR for past 6 years • Est. 65% market share All India. • Available over 160000 outlets Pan India.
Slide 15: EVA
EVA • Positioned as a teen girls brand. • Bought from Sara Lee in 2003. • Differentiated Offering – First brand without alcohol, skin friendly and ph balanced. • Market leader for over 5 years in the Women's Deo segment - 23% market share* (Mar, 2016). • Managed against stiff competition from MNC br
Slide 16: Good Home
Good Home GOOD HOME • Good Home Launched in 2007 Provides Innovative Home Care Solution to Daily consumer needs • Present across Air Fresheners, Kitchen Cleaners, Scrubbers, Drain Cleaners, Odour Remover, etc. • Available over 140000 outlets across India • Innovative New products in the pipeline
Slide 17: Skore
Skore • Skore – Launched in Nov 12. • Coloured , flavoured range for the first time in India. • Rapid distribution reaching over 150,000 and above. • Clutter breaking advertising. • Awarded ‘Silver’ in Appies 2016- Asia Pacific marketing effectiveness award • Scaled to 10% market share within the fi
Slide 18: Distribution
Distribution Unique structure National Large sales force with multiple presence channels 29 branch Over 700 Modern locations format Sales People Traditional Retail 136000 sq.ft of Committed CSD warehousing and well qualified sales Pharmacies 400000+ management Team Police outlets Canteens
Slide 19: Distribution Structure
Distribution Structure Traditional Modern Institutions Trade Trade Authorized Wholesale Hypermarkets CSD Distributors Super markets Police Canteens Health & Beauty Chains Pharmacy Chains Pharmacies Dept. Stores Groceries Cosmetics Others
Slide 20: Distribution
Distribution • Listed across key modern trade chains • Presence in 2200+ outlets across chains Modern Trade Chain outlets Outlet universe 2312 Outlets covered 2227 % coverage 96% Channel-wise distribution Channel Chemists Grocers General Cosmeti Self service Others Total Merchant c Stores super s ma
Slide 21: Pharma Business
HEALTHCARE Pharma Business "eee
Slide 22: Pharma Business
Pharma Business Human Pharma Animal Pharma Bovianim Gallus Companim Endura Ventura Gynec and Infertility Livestock Poultry Pet others and Gynec Products Products Products
Slide 23: IPM v/s TTKHC
IPM v/s TTKHC Total IPM Rs. 102537 Cr. TTK CVM Rs.8234 Cr . (8%) IPM – Indian Pharma Market CVM – Covered Market Pharmatrac Aug ‘16 MAT
Slide 24: TTKHC Share in CVM
TTKHC Share in CVM TTKHC CVM: Rs.8234 Cr. TTKHC Rs.185 Cr. CVM – Covered Market Pharmatrac Aug ‘16 MAT
Slide 25: Specialties Covered
Customer Profile Specialties Covered Endura Ventura Gynecologists Gynecologists GPs & Physicians Infertility/ Urologists General Surgeons & Physicians and GPs Orthopedic surgeons Pediatricians Pediatricians Dermatologists/ ENT, Urologists, Sexologists Chest Physicians Orthopaedic Surgeons
Slide 26: Total Doctors / Chemists Covered
Total Doctors / Chemists Covered Doctors Chemists Endura 72000 50000 Ventura 68800 53750 Note: Doctors Coverage includes Gynecologists, Infertility specialists, GPs, Orthopaedicians, Urologists / Andrologists, Pediatricians, Sexologists, ENT, Surgeons .
Slide 27: Product Range
Product Range SEGMENT BRAND Analgesic/ Anti-inflammatory Dolobest P Tabs, Dolobest MR, Penetrat & Penetrat D Levocold Syp, Levokast Tabs, Levokast Kid Tabs, Levokast AX, Anti allergic Levokast Susp & Monokast FX Tabs Anti asthmatic Monokast AB & Monokast Tabs Anti spasmodics Epidosin Tabs and Urifre
Slide 28: Product Range
Product Range SEGMENT BRAND Lukure Tabs, Lactare Caps, Lactare Granules, LR Zin Granules, LR Zin Forte Granules, LR Zin beta, Climacter Caps, ChromiNAC-,A, Utronorm Gynae Care Forte Syrup, Utronorm Syrup, Normonal CR, KG Cut, Trus D, Tamik BC, Delivera P 200/300 and Protogen MOM. Haematinics Hemobes
Slide 29: Major Brands - Endura
Major Brands - Endura 2015-16 Rs. in Cr. 19.55 20 18 16 14 11.46 12 10 7.5 8 6 3.04 2.81 4 2 0 Ossopan Epidosin Levokast Oricitral Tamik BC
Slide 30: Major Brands - Ventura
Major Brands - Ventura 2015-16 2015-16 Rs. in Cr. 14 12.69 12 9.89 10 8 6.67 5.6 5.37 6 4.67 4 2 0 Lactare CCQ LRzin ChromiNAC-A Carni - Q Eva Serve
Slide 31: Distribution Network
Distribution Network Depots 25 Stockists 1500
Slide 32: Animal Welfare Division
Animal Welfare Division
Slide 33: Market Size, Customer Profile & Coverage
Market Size, Customer Profile & Coverage • Presence in Rs.4,200 Crores market, growing at 11%. Our share is 1.1% at Rs.44 Crores. • Operating through 3 distinct Divisions – Bovianim, Gallus & Companim. • Pan India operation. • Customer profile includes Veterinarians, Para-Vets, Cattle Farmers, Dairi
Slide 34: Product Range
Product Range • Calcium Supplements • Calcium Supplements • Calcium Supplements • Liver Tonic • Liver Tonic • Skincare • Fertility Promoter • Vitamins • Liver Tonic • Anti-Parasitics • Anti-Infectives • NSAID • Anti-Infectives • Enzymes • Dog Treats • Nutritional • Acidifiers • Anti-Infectives Suppl
Slide 35: Key Brands
Key Brands 2015-16 Rs. in Cr. 6.63 6.62 7 5.38 6 5 4 2.28 1.99 3 2 1 0 Orcal - P Ossomin Tefroli Nemoclox - Lysetik D
Slide 36: Medical Devices Business
HEALTHCARE Medical Devices Business
Slide 37: TTK Chitra Heart Valves
TTK Chitra Heart Valves MONOLEAFLET TILTING DISC MECHANICAL VALVE
Slide 38: TTK Chitra Heart Valves
TTK Chitra Heart Valves • India's first and only indigenous Heart Valve prosthesis. • State- of- art facility at Trivandrum. • First implant in India – 1990. • More than 100,000 implants as on date. • No structural dysfunction reported. • More than 280 leading cardiac centres in India using the Valv
Slide 39: TTK Chitra Heart Valves
TTK Chitra Heart Valves TTK Chitra Heart Valves is today a leading brand in India and has given a new lease of life to people suffering from cardiac problems, necessitating Heart Valve replacements.
Slide 40: Mobile Bearing Knee Replacement System
Buechel-Pappas Mobile Bearing Knee Replacement System
Slide 41: Mobile Bearing Knee Replacement System
Buechel-Pappas Mobile Bearing Knee Replacement System • Forayed into the Orthopaedic business in 2009. • Technical collaboration with BP Trust, USA – promoted by the internationally renowned Dr Buechel and Dr Pappas. • Advanced 3rd Generation New Jersey Knee - this is the Mobile Bearing version as c
Slide 42: Buechel-Pappas Product Range
Buechel-Pappas Mobile Bearing Knee Replacement System Product Range Cemented CoCr Cemented All Poly Tibial Titanium Knee Knee Implants Platform Implants Cementless Cemented Hip Hinge Knee Revision Knee Titanium Knee Implants Implants Implants Implants
Slide 43: Buechel-Pappas Mobile Bearing Knee Replacement System
Buechel-Pappas Mobile Bearing Knee Replacement System ♦ Range of motion up to 162 degree angle. ♦ No Dislocation - Stop pin engages with the slot in the bearing to limit bearing rotation-and prevents spin out. ♦ Lowest Contact Stress - Femoral component's congruent contact and area contact with the
Slide 44: Certifications
Buechel-Pappas Mobile Bearing Knee Replacement System Certifications • ISO 9001:2008 by DNV • ISO 13485:2003 by DNV • CE Marking by DNV • Drug License by Central and State Drug Authorities, India
Slide 45: Foods Business
Beller] ©. HEALTHCARE Foods Business "eee
Slide 46: Ready To Fry Pellets (Pappad)
Ready To Fry Pellets (Pappad)
Slide 47: Ready To Fry Pellets (Pappads)
Ready To Fry Pellets (Pappads) • TTK forayed into the foods business in early 1985 – The First in India. • TTK has two manufacturing facilities – one at Hosakote and the other at Jaipur. • Current Capacity - 16,400 MTs Per Annum. • Types of Pellets(Pappads) : Cereal, Potato & Flavoured (Onion, Garli
Slide 48: Financials
Financials
Slide 49: Sales Trend
Sales Trend Year Rs. Lakhs 2008-09 21990 2009-10 25243 2010-11 31030 2011-12 35336 2012-13 38191 2013-14 41569 2014-15 48276 2015-16 51503
Slide 50: Sales Trend
Sales Trend Rs. in Lakhs 60000 48276 51503 50000 41569 38191 35336 40000 31030 25243 30000 21990 20000 10000 0 2008-09 2009-10 2010-11 2011-12 2012-13 2013-14 2014-15 2015-16
Slide 51: Division wise Revenue
Division wise Revenue Rs. in Lakhs Year Pharmaceuticals Medical Consumer Foods Others Total Devices Products OTC Non-OTC 2008-09 3481 7916 1591 7976 870 156 21990 2009-10 3943 8722 1887 9570 899 222 25243 2010-11 4888 10377 1984 12495 991 295 31030 2011-12 5555 12231 1723 14105 1349 373 35336 2012-1
Slide 52: EBIDTA/Capital Employed Ratio
EBIDTA/Capital Employed Ratio Capital EBIDTA Year Employed * EBIDTA (%) (Rs. Lakhs) (Rs. Lakhs) 2008-09 1698 5733 29.62 2009-10 1906 5996 31.79 2010-11 2583 7107 36.34 2011-12 2847 8308 34.27 2012-13 2689 9366 28.71 2013-14 2583 10241 25.22 204-15 3612 11381 31.74 2015-16 4606 13180 34.95 Note :- *
Slide 53: EBIDTA/Capital Employed Ratio
EBIDTA/Capital Employed Ratio EBIDTA (%) 40 36.34 34.95 34.27 35 31.79 28.71 31.74 29.62 30 25 20 25.22 15 10 5 0 2008-09 2009-10 2010-11 2011-12 2012-13 2013-14 2014-15 2015-16
Slide 54: EBIDTA/Turnover Ratio
EBIDTA/Turnover Ratio EBIDTA Turnover EBIDTA Year (Rs. Lakhs) (Rs. Lakhs) % 2008-09 1698 21990 7.72 2009-10 1906 25243 7.55 2010-11 2583 31030 8.32 2011-12 2847 35336 8.06 2012-13 2689 38191 7.04 2013-14 2583 41569 6.21 2014-15 3612 48276 7.48 2015-16 4606 51503 8.94
Slide 55: EBIDTA/Turnover Ratio
EBIDTA/Turnover Ratio EBIDTA (%) 10 8.94 7.55 8.32 8.06 7.72 7.04 7.48 5 6.21 0 2008-09 2009-10 2010-11 2011-12 2012-13 2013-14 2014-15 2015-16
Slide 56: Going Forward
GOING FORWARD 29> >
Slide 57: Way Forward
Way Forward CONSUMER PRODUCTS DIVISION • To exploit the full potential of the existing consumer brands viz. Woodwards, EVA and Good Home through appropriate promotional investments. • Increasing Distribution reach for all Brands. • To Launch carefully chosen new products that are complementary to th
Slide 58: Way Forward
Way Forward MEDICAL DEVICES DIVISION • To grow the volumes of existing Heart Valve and to gain further volumes through launch of Bi-Leaflet / Tissue Valves (Distribution Lines); and • To grow the Ortho business through geographical expansion, launch of new products and accelerating doctor conversion
Slide 59: Way Forward
Way Forward FINANCIAL GOAL • Depending upon favourable Macro economic conditions, achieving a financial goal of CAGR of 15% in turnover over the next four years, with EBIDTA of 9-11% . TO SUM UP: • To take the Company into new levels of Brand strength, Market Reach and Profitability. • All the above
Slide 60: Thank You
HEALTHCARE THANK YOU
TTK Healthcare — Investor Presentation (September 2016) on 6ix